Jianren Mao Selected Research

ICI D2788

1/2018	Increased HCN Channel Activity in the Gasserian Ganglion Contributes to Trigeminal Neuropathic Pain.
9/2016	Inhibition of HCN channel activity in the thalamus attenuates chronic pain in rats.
1/2016	Neuropeptide S modulates the amygdaloidal HCN activities (Ih) in rats: Implication in chronic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianren Mao Research Topics

Disease

61	Pain (Aches) 12/2021 - 07/2000
34	Chronic Pain 12/2021 - 07/2000
34	Hyperalgesia 01/2021 - 09/2002
25	Neuralgia (Stump Neuralgia) 01/2021 - 07/2000
11	Peripheral Nerve Injuries 01/2016 - 09/2003
8	Inflammation (Inflammations) 01/2020 - 01/2006
7	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 07/2011
5	Burns 01/2021 - 07/2005
3	Cognitive Dysfunction 08/2018 - 11/2013
3	Radiculopathy (Radiculopathy, Cervical) 05/2018 - 03/2013
2	Postoperative Pain 01/2020 - 01/2020
2	Critical Illness (Critically Ill) 01/2019 - 01/2019
2	Trigeminal Nerve Injuries 01/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 02/2009 - 08/2008
2	Cancer Pain 09/2008 - 03/2007
2	Disease Progression 09/2008 - 12/2007
2	Nervous System Diseases (Neurological Disorders) 08/2008 - 02/2005
2	Substance-Related Disorders (Drug Abuse) 03/2005 - 09/2002
1	Neck Pain (Cervicalgia) 12/2021
1	Intervertebral Disc Displacement (Herniated Disc) 11/2019
1	Spinal Cord Diseases 01/2019
1	Memory Disorders (Memory Loss) 08/2018

Drug/Important Bio-Agent (IBA)

42	Opioid Analgesics (Opioids)IBA 01/2021 - 09/2002
15	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 09/2002
11	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 09/2002
8	Analgesics (Analgesic Drugs)IBA 01/2020 - 09/2002
6	N-Methylaspartate (NMDA)IBA 05/2014 - 01/2009
6	Glutamic Acid (Glutamate)FDA Link 08/2008 - 09/2002
5	salicylhydroxamic acid (SHAM)IBA 12/2021 - 07/2005
5	Ketamine FDA LinkGeneric 12/2017 - 12/2004
5	Pharmaceutical PreparationsIBA 04/2016 - 06/2006
5	Dizocilpine Maleate (Dizocilpine)IBA 06/2011 - 09/2002
5	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 09/2007 - 09/2004
4	Gabapentin (Neurontin)FDA LinkGeneric 12/2021 - 12/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2004
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
4	Therapeutic UsesIBA 01/2019 - 07/2000
4	Antidepressive Agents (Antidepressants)IBA 01/2019 - 02/2011
4	SteroidsIBA 05/2018 - 10/2007
4	Freund's AdjuvantIBA 01/2013 - 01/2009
4	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2011 - 12/2004
3	NF-kappa B (NF-kB)IBA 01/2021 - 01/2006
3	Buprenorphine (Subutex)FDA LinkGeneric 01/2020 - 08/2015
3	ICI D2788IBA 01/2018 - 01/2016
3	Midazolam (Versed)FDA LinkGeneric 01/2017 - 12/2006
3	CannabinoidsIBA 04/2016 - 09/2003
3	Lidocaine (Xylocaine)FDA LinkGeneric 03/2013 - 07/2000
3	MelatoninIBA 12/2012 - 03/2008
3	Mifepristone (RU 486)FDA Link 10/2007 - 09/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2017
2	Local AnestheticsIBA 01/2020 - 03/2013
2	BenzodiazepinesIBA 01/2019 - 12/2006
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016 - 08/2014
2	Diclofenac (SR 38)FDA LinkGeneric 07/2015 - 09/2007
2	chelerythrineIBA 05/2014 - 09/2003
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2014 - 02/2013
2	Glial Fibrillary Acidic ProteinIBA 12/2012 - 08/2009
2	LeptinIBA 06/2011 - 02/2009
2	AdipokinesIBA 06/2011 - 02/2009
2	Protein Kinase CIBA 01/2011 - 09/2003
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 08/2008 - 04/2003
2	Triamcinolone (Aristocort)FDA Link 01/2008 - 10/2007
2	Antisense OligonucleotidesIBA 09/2007 - 09/2004
2	Protein Kinases (Protein Kinase)IBA 07/2005 - 09/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2005 - 09/2004
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2003 - 04/2003
2	Riluzole FDA LinkGeneric 04/2003 - 09/2002
1	MelanocortinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	CalciumIBA 01/2021
1	CytokinesIBA 01/2021
1	InterleukinsIBA 01/2021
1	methyllycaconitineIBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2021
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020
1	MMEIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Cyclic Nucleotide-Gated Cation ChannelsIBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2019
1	NocodazoleIBA 08/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2018
1	TubulinIBA 08/2018

Therapy/Procedure

31	Therapeutics 12/2021 - 07/2000
5	Pain Management 01/2019 - 12/2007
3	Acupuncture Therapy 12/2021 - 04/2010
3	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 02/2011
2	Electroacupuncture 12/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2020 - 10/2015
2	Injections 05/2018 - 03/2013
2	Spinal Cord Stimulation 11/2017 - 07/2015
2	Drug Therapy (Chemotherapy) 09/2017 - 12/2011
2	Duration of Therapy 05/2009 - 05/2008
1	Drug Tapering 11/2019
1	Intraventricular Infusions 08/2018